Therapy Areas: Devices
Foundation Medicine, Day One Biopharmaceuticals Forge Collaboration to Advance Pediatric Cancer Care
23 September 2022 - - US-based Foundation Medicine, Inc., a specialist in molecular profiling for cancer, and US-based clinical-stage biopharmaceutical company Day One Biopharmaceuticals (NA...
US Medical Innovations Raises USD 10.2m in Private Placement
22 September 2022 - - US-based US Patent Innovations, LLC's US Medical Innovations, LLC biomedical device subsidiary has secured a USD 10.2m private placement deal from multiple sources including...
Hoth Therapeutics signs manufacturing agreement with Altasciences for HT-TBI therapy for secondary brain injury
20 September 2022 - Biopharmaceutical company Hoth Therapeutics Inc (NASDAQ: HOTH) announced on Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to d...
Insulet receives CE Mark approval for Omnipod 5 Automated Insulin Delivery System
20 September 2022 - Insulet Corporation (NASDAQ: PODD), a provider of tubeless insulin pump technology with its Omnipod brand of products, reported on Tuesday that its Omnipod 5 Automated Insulin Deli...
FDA Approves RECOVER IV Randomized Controlled Trial with Exception from Informed Consent
16 September 2022 - - US-based medical technology company Abiomed (NASDAQ: ABMD) has received two approvals from the US Food and Drug Administration related to clinical research of Impella heart ...
AVS Announces Multi-Site Enrollment of First Patients in POWER PAD I Clinical Trial
16 September 2022 - - US-based medical device company AVS has posted enrollment, successful treatment, and positive 30-day follow up data of the first patients in the POWER PAD I clinical trial.